Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation

J Immunol. 2006 Jan 15;176(2):721-5. doi: 10.4049/jimmunol.176.2.721.

Abstract

Host response to infectious agents must be rapid and powerful. One mechanism is the release of presynthesized membrane-bound TNF. TNF shedding is mediated by TNF-alpha converting enzyme, which is selectively inhibited by the tissue inhibitor of metalloproteinase 3 (TIMP3). We show that loss of TIMP3 impacts innate immunity by dysregulating cleavage of TNF and its receptors. Cultured timp3-/- macrophages release more TNF in response to LPS than wild-type macrophages. In timp3-/- mice, LPS causes serum levels of TNF and its receptors to rise more rapidly and remain higher compared with wild-type mice. The altered kinetics of ligand and receptor shedding enhances TNF signaling in timp3-/- mice, indicated by elevated serum IL-6. Physiologically, timp3-/- mice are more susceptible to LPS-induced mortality. Ablation of the TNF receptor gene p55 (Tnfrsf1a) or treatment with a synthetic metalloproteinase inhibitor rescues timp3-/- mice. Thus, TIMP3 is essential for normal innate immune function.

MeSH terms

  • Animals
  • Cells, Cultured
  • Immunity, Innate
  • Inflammation / immunology*
  • Kinetics
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects
  • Macrophages / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, Tumor Necrosis Factor / metabolism
  • Tissue Inhibitor of Metalloproteinase-3 / deficiency
  • Tissue Inhibitor of Metalloproteinase-3 / genetics
  • Tissue Inhibitor of Metalloproteinase-3 / immunology*
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Lipopolysaccharides
  • Receptors, Tumor Necrosis Factor
  • Tissue Inhibitor of Metalloproteinase-3
  • Tumor Necrosis Factor-alpha